Chronic neutrophilic leukemia historical perspective: Difference between revisions
Jump to navigation
Jump to search
Homa Najafi (talk | contribs) |
Homa Najafi (talk | contribs) |
||
Line 11: | Line 11: | ||
* In 2001, WHO introduced the criteria for diagnosis CNL as a myeloproliferative disorder that was revised in 2016. | * In 2001, WHO introduced the criteria for diagnosis CNL as a myeloproliferative disorder that was revised in 2016. | ||
* In 2013, CSF3R (colony stimulating factor 3 receptor) mutations was proposed that was found in the most CNL patients. | * In 2013, CSF3R (colony stimulating factor 3 receptor) mutations was proposed that was found in the most CNL patients. | ||
==References== | ==References== | ||
[[Category: (name of the system)]] | [[Category: (name of the system)]] |
Revision as of 14:38, 21 January 2019
Chronic neutrophilic leukemia Microchapters |
Differentiating Chronic neutrophilic leukemia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Chronic neutrophilic leukemia historical perspective On the Web |
American Roentgen Ray Society Images of Chronic neutrophilic leukemia historical perspective |
Chronic neutrophilic leukemia historical perspective in the news |
Blogs on Chronic neutrophilic leukemia historical perspective |
Directions to Hospitals Treating Chronic neutrophilic leukemia |
Risk calculators and risk factors for Chronic neutrophilic leukemia historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Historical Perspective
Discovery
- Chronic neutrophilic leukemia(CNL) was first presented by Tuohy, in a case of splenomegaly and neutrophilic leukocytosis, in 1920. Although, It was named by Tanzer et al, in 1964.
- In 2001, WHO introduced the criteria for diagnosis CNL as a myeloproliferative disorder that was revised in 2016.
- In 2013, CSF3R (colony stimulating factor 3 receptor) mutations was proposed that was found in the most CNL patients.